MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 341486 | Name: Xylocholine

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Xylocholine is a biochemical.

Chemical Structure

Xylocholine
Xylocholine
CAS#669-50-1

Theoretical Analysis

MedKoo Cat#: 341486

Name: Xylocholine

CAS#: 669-50-1

Chemical Formula: C13H22NO+

Exact Mass: 208.1696

Molecular Weight: 208.32

Elemental Analysis: C, 74.95; H, 10.64; N, 6.72; O, 7.68

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Xylocholine;
IUPAC/Chemical Name
Ethanaminium, 2-(2,6-dimethylphenoxy)-N,N,N-trimethyl-
InChi Key
RXYWAURTGUPANZ-UHFFFAOYSA-N
InChi Code
InChI=1S/C13H22NO/c1-11-7-6-8-12(2)13(11)15-10-9-14(3,4)5/h6-8H,9-10H2,1-5H3/q+1
SMILES Code
Cc1cccc(c1OCC[N+](C)(C)C)C
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 208.32 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Orre M, Pennefather JN, Story ME, Haynes JM. The effects of P2 purinoceptor agonists on the isolated portal vein of the guinea pig. Eur J Pharmacol. 1996 Dec 5;316(2-3):229-36. PubMed PMID: 8982691. 2: Boura AL, Green AF. Noradrenergic neurone blocking agents. J Auton Pharmacol. 1981 Jun;1(3):255-67. PubMed PMID: 7040400. 3: Fielden R. The discovery of the noradrenergic neurone blocking action of TM10 (xylocholine). J Auton Pharmacol. 1981 Jun;1(3):251-4. PubMed PMID: 7040399. 4: Heitz DC, Brody MJ. Possible mechanism of histamine release during active vasodilatation. Am J Physiol. 1975 May;228(5):1351-7. PubMed PMID: 48345. 5: Prasad CM, Shah DS, Gulati OD. Some factors affecting the neuron blocking action of guanethidine, xylocholine, bretylium and debrisoquin. Jpn J Pharmacol. 1973 Dec;23(6):805-11. PubMed PMID: 4544694. 6: Hughes IE, Leak CM. Uptake of ( 14 C)xylocholine in mouse vas deferens after chemical sympathectomy. J Pharm Pharmacol. 1972 Sep;24(9):749-50. PubMed PMID: 4404086. 7: Dean HG, Hughes IE. Increased release of xylocholine (TM10) from guinea-pig vas deferens treated with amphetamine sulphate. J Pharm Pharmacol. 1972 Mar;24(3):183-8. PubMed PMID: 4402776. 8: Dean HG, Hughes IE. Effect of amphetamine on the uptake, release and effectiveness of xylocholine in the guinea-pig vas deferens. J Pharm Pharmacol. 1971 Aug;23(8):606-11. PubMed PMID: 4397745. 9: Coggon P, McPhail AT, Roe AM. Conformation of xylocholine. Nature. 1969 Dec 20;224(5225):1200-1. PubMed PMID: 5358339. 10: Schnizer W. [Effect of desipramine, cocaine and xylocholine on 5-hydroxytryptamine, adrenaline and vagus stimulation induced tonus decrease of smooth frog lung musculature]. Arzneimittelforschung. 1969 Apr;19(4):663-5. German. PubMed PMID: 5819171. 11: Clark ER, Jana M. The identification of the impurity responsible for the reported pressor activity of xylocholine. Br J Pharmacol Chemother. 1966 May;27(1):135-44. PubMed PMID: 5961461; PubMed Central PMCID: PMC1510797. 12: FIELDEN R, ROE AM, WILLEY GL. THE ADRENERGIC-NEURONE BLOCKING ACTION OF SOME COUMARAN COMPOUNDS. Br J Pharmacol Chemother. 1964 Dec;23:486-507. PubMed PMID: 14256809; PubMed Central PMCID: PMC1704011. 13: BHAGAT B. MODIFICATION OF THE EFFECTS OF GUANETHIDINE ON CARDIAC CATECHOL AMINES BY VARIOUS AGENTS. Br J Pharmacol Chemother. 1964 Apr;22:238-45. PubMed PMID: 14190459; PubMed Central PMCID: PMC1703988. 14: ROBERTS J, ITO R, REILLY J, CAIROLI VJ. INFLUENCE OF RESERPINE AND BETA TM 10 ON DIGITALIS-INDUCED VENTRICULAR ARRHYTHMIA. Circ Res. 1963 Aug;13:149-58. PubMed PMID: 14047640. 15: BURN JH, FROEDE H. The action of substances which block sympathetic postganglionic nervous transmission. Br J Pharmacol Chemother. 1963 Apr;20:378-87. PubMed PMID: 14017105; PubMed Central PMCID: PMC1703641. 16: WILLEY GL. Effect of antisympathomimetic drugs on the plasma concentrations of catechol amines. Br J Pharmacol Chemother. 1962 Dec;19:365-74. PubMed PMID: 14000807; PubMed Central PMCID: PMC1482210. 17: DAY MD. Effect of sympathomimetic amines on the blocking action of guanethidine, bretylium and xylocholine. Br J Pharmacol Chemother. 1962 Apr;18:421-39. PubMed PMID: 13884064; PubMed Central PMCID: PMC1482112. 18: AVIADO DM. Sympathetic nerve blocking drugs for the treatment of hypertension. TM-10, beta TM-10, bretylium and guanethidine. Am J Med Sci. 1961 May;241:650-61. PubMed PMID: 13685282.